Cell Press
Ticks have had millions of years to figure out how to bite
without triggering their victims' immune response. Proteins in the arachnids'
spit evolved to manipulate immune cells so that the bloodsuckers can suck blood
and transmit pathogens in peace.
But these measures may not always have the
desired effect when ticks bite humans, leading to severe allergic reactions,
argue infectious disease specialists in an Opinion published on September 25 in Trends
in Parasitology. The researchers believe a vaccine for tick bite allergies
could be developed from the spit allergen, once it is identified.
Only recently has it been known that tick bites even cause
allergic reactions. Thousands of people are affected each year--particularly in
the United States and Australia, with more and more diagnosed as doctors learn
of the allergy, and as tick and human contact increases as a result of climate
change and habitat loss.
Depending on the tick species and the person, bites
can result in allergic reactions ranging from an itch to full anaphylactic
shock. Tick bites might also induce the development of red meat or gelatin
allergies.
"We believe that there are proteins in the
tick saliva modified by a compound called alpha-gal that changes the immune
response in humans, so that it is possible to have these allergic
reactions."
The alpha-gal modified proteins are de la Fuente's prime suspect
because alpha-gal is not synthesized by humans and apes, and so it could be
that when a tick bites us and introduces the protein into the skin, our immune
system's natural response is to label it as "foreign" and attack.
This would explain why later exposure to red meat, which possesses a variation
of alpha-gal, can cause an immune reaction. An immune memory against alpha-gal
may also have a protective effect as people previously exposed to the molecule
are less likely to get malaria, a mosquito-borne disease, indicating that other
insects could carry alpha-gal in their bites.
Whether the tick saliva allergen is alpha-gal or something else,
knowing the culprit can lead to the production of an antivenom-like product
that minimizes the bite immune response. Another strategy would be to create a
vaccine that could numb the immune system to the presence of what is causing
the allergy.
"No specific treatment for a tick bite allergy is currently
available," de la Fuente says. "Anyone who lives in a risk area or is
moving to a region with many reported cases would benefit from such a
vaccine."